Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings reported notable year-over-year growth in several key areas, including Full-Service Provider (FSP), Real World Evidence (RWE), and Contract Sales Management Services (CSMS), contributing to an optimistic outlook for the company's performance. The company is experiencing positive momentum in its commercial segment, facilitated by improved client decision timelines and a robust pipeline, primarily driven by recent drug launches. Moreover, IQVIA's confidence in achieving a growth rate exceeding 4% for its Research and Development Solutions (R&D) segment on a constant currency basis, along with an improved pricing environment, further underpins a strong financial outlook.

Bears say

The financial analysis highlights several fundamental concerns regarding IQVIA Holdings' outlook. The company experienced a notable decline in year-over-year constant currency (YOY CC) growth, which fell to 3.8% in 3Q25 from 6.8% in the previous quarter, signaling a potential slowdown amid challenging comparisons from the previous year. Additionally, the concern surrounding rising interest rates poses a risk to earnings, as the company's floating/fixed rate mix may face increased pressure, impacting overall profitability and margin performance.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Jan 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $248.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $248.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.